|Podcasts|February 7, 2023
The Rewarding Path Of Science
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
Related Content
Trending on Applied Clinical Trials Online
1
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
2
When the Slack Runs Out: AI and the CRO Operating Model
3
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5